First Author | Xu H | Year | 2018 |
Journal | Nat Commun | Volume | 9 |
Issue | 1 | Pages | 4118 |
PubMed ID | 30297767 | Mgi Jnum | J:267606 |
Mgi Id | MGI:6267830 | Doi | 10.1038/s41467-018-06409-5 |
Citation | Xu H, et al. (2018) Dopamine-endocannabinoid interactions mediate spike-timing-dependent potentiation in the striatum. Nat Commun 9(1):4118 |
abstractText | Dopamine modulates striatal synaptic plasticity, a key substrate for action selection and procedural learning. Thus, characterizing the repertoire of activity-dependent plasticity in striatum and its dependence on dopamine is of crucial importance. We recently unraveled a striatal spike-timing-dependent long-term potentiation (tLTP) mediated by endocannabinoids (eCBs) and induced with few spikes (~5-15). Whether this eCB-tLTP interacts with the dopaminergic system remains to be investigated. Here, we report that eCB-tLTP is impaired in a rodent model of Parkinson's disease and rescued by L-DOPA. Dopamine controls eCB-tLTP via dopamine type-2 receptors (D2R) located presynaptically in cortical terminals. Dopamine-endocannabinoid interactions via D2R are required for the emergence of tLTP in response to few coincident pre- and post-synaptic spikes and control eCB-plasticity by modulating the long-term potentiation (LTP)/depression (LTD) thresholds. While usually considered as a depressing synaptic function, our results show that eCBs in the presence of dopamine constitute a versatile system underlying bidirectional plasticity implicated in basal ganglia pathophysiology. |